Temporal interference stimulation targets deep brain regions by modulating neural oscillations.
Zeinab Esmaeilpour, Greg Kronberg, Davide Reato...
https://pubmed.ncbi.nlm.nih.gov/33186778/Actively Recruiting
Led by Qilu Hospital of Shandong University · Updated on 2026-09-21
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a new device-based treatment for chronic non-specific low back pain using dual-carrier-frequency transcranial alternating current stimulation targeting the hippocampus. This randomized, double-blind, sham-controlled trial includes 60 patients divided into four groups active stimulation, active stimulation with intermittent theta-burst stimulation iTBS, superficial cortical stimulation control, and sham control. The studys main goal is to assess improvements in pain intensity and emotional symptoms after two weeks of treatment. Participants receive 20-minute stimulation sessions five times per week over two weeks, totaling ten sessions. The first group receives dual-frequency stimulation targeting deep brain areas, the second group adds iTBS to this stimulation, the third group receives cortical electrical stimulation on the somatosensory cortex, and the fourth group undergoes sham stimulation with no actual current output. All groups also receive standard pain rehabilitation immediately after each session. Throughout the study, participants undergo multiple assessments including pain scales, emotional health questionnaires, functional brain imaging fMRI, MEG, fNIRS, and electrophysiology EEG, EMG. Measurements are taken at baseline, after the first session, mid-treatment, end of treatment, and at a two-week follow-up. Researchers will analyze these data to explore clinical effects and brain connectivity changes related to the interventions. The total participation period covers the two-week treatment and the subsequent follow-up.
CONDITIONS
A Study on the Efficacy of Dual-Carrier-Frequency Transcranial Alternating Current Stimulation Modulating the Hippocampus for the Treatment of Chronic Non-Specific Low Back Pain
X
Xiaofei Zhang
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Qilu Hospital of Shandong University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 2 weeks
Participants receive one of four types of brain stimulation or sham treatment, each session lasting 20 minutes, five times per week for two weeks, along with standard pain rehabilitation after each session.
10 sessions over 2 weeks
Duration - 2 weeks
Participants are monitored for two weeks after treatment to assess pain levels, emotional symptoms, and brain function.
Follow-up assessments at 2 weeks post-treatment
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Zeinab Esmaeilpour, Greg Kronberg, Davide Reato...
https://pubmed.ncbi.nlm.nih.gov/33186778/Pierre Vassiliadis, Elena Beanato, Traian Popa...
https://pubmed.ncbi.nlm.nih.gov/38811696/Sarah Onuora
https://pubmed.ncbi.nlm.nih.gov/37430106/Ru Ma, Xinzhao Xia, Wei Zhang...
https://pubmed.ncbi.nlm.nih.gov/35046771/Ilya Demchenko, Ishaan Tailor, Sina Chegini...
https://pubmed.ncbi.nlm.nih.gov/40463528/Jiawei Zhang, Xiaoting Zheng, Gaoyan Zhang...
https://pubmed.ncbi.nlm.nih.gov/40527933/Nûno Trolle, Thomas Maribo, Lone Donbæk Jensen...
https://pubmed.ncbi.nlm.nih.gov/31663814/Dongcheng Wang, Zhe Du, Xinwen Wen...
https://pubmed.ncbi.nlm.nih.gov/41389502/Martin Lamoš, Martina Bočková, Florian Missey...
https://pubmed.ncbi.nlm.nih.gov/40202094/Ming Ding, Shitong Xiang, Yuqing Zhang...
https://pubmed.ncbi.nlm.nih.gov/41855330/Qilu Hospital of Shandong University
Lead Sponsor